Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States(1)

BACKGROUND: Neoadjuvant chemotherapy (NACT) for the treatment of muscle-invasive bladder cancer (MIBC) remains underutilized in the United States despite evidence supporting its use. OBJECTIVES: To examine the perioperative chemotherapy management of patients with MIBC by medical oncologists (MedOnc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Urol Oncol
Autores principales: Apolo, Andrea B., Kim, Joseph W., Bochner, Bernard H., Steinberg, Seth M., Bajorin, Dean F., Kelly, Wm. Kevin, Agarwal, Piyush K., Koppie, Theresa M., Kaag, Matthew G., Quinn, David I., Vogelzang, Nicholas J., Sridhar, Srikala S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6771274/
https://ncbi.nlm.nih.gov/pubmed/24840869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2013.12.012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares